540788
ASPIRA
Start SIP
Invest Now
Start SIP in ASPIRA
Performance
- Low
- ₹62
- High
- ₹65
- 52 Week Low
- ₹50
- 52 Week High
- ₹107
- Open Price₹62
- Previous Close₹65
- Volume10
- 50 DMA₹64.59
- 100 DMA₹64.16
- 200 DMA₹62.89
Investment Returns
- Over 1 Month + 2.68%
- Over 3 Month + 0.56%
- Over 6 Month + 4.42%
- Over 1 Year -16.8%
Smart Investing Starts Here Start SIP with Aspira Pathlab & Diagnostics for Steady Growth!
Aspira Pathlab & Diagnostics Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 19.6
- PEG Ratio
- 0
- Market Cap Cr
- 67
- P/B Ratio
- 4.6
- Average True Range
- 3.99
- EPS
- -
- Dividend Yield
- 0
- MACD Signal
- -0.31
- RSI
- 50.25
- MFI
- 45.27
Aspira Pathlab & Diagnostics Financials
Aspira Pathlab & Diagnostics Technicals
EMA & SMA
Current Price
₹64.69
-0.32
(-0.49%)
- Bearish Moving Average 2
- Bullish Moving Average 14
- 20 Day
- ₹64.47
- 50 Day
- ₹64.59
- 100 Day
- ₹64.16
- 200 Day
- ₹62.89
Resistance and Support
63.73
- R3 68.54
- R2 66.62
- R1 65.65
- S1 62.76
- S2 60.84
- S3 59.87
Aspira Pathlab & Diagnostics Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2025-11-12 | Quarterly Results | |
| 2025-08-12 | Quarterly Results | |
| 2025-05-16 | Audited Results | |
| 2025-02-07 | Quarterly Results | |
| 2024-11-12 | Quarterly Results |
Aspira Pathlab & Diagnostics F&O
About Aspira Pathlab & Diagnostics
- NSE Symbol
- ASPIRA
- BSE Symbol
- 540788
- Managing Director & CEO
- Dr. Pankaj J Shah
- ISIN
- INE500C01017
Similar Stocks to Aspira Pathlab & Diagnostics
Aspira Pathlab & Diagnostics FAQs
Aspira Pathlab & Diagnostics share price is ₹64 As on 26 January, 2026 | 05:22
The Market Cap of Aspira Pathlab & Diagnostics is ₹66.6 Cr As on 26 January, 2026 | 05:22
The P/E ratio of Aspira Pathlab & Diagnostics is 19.6 As on 26 January, 2026 | 05:22
The PB ratio of Aspira Pathlab & Diagnostics is 4.6 As on 26 January, 2026 | 05:22
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.